Molecular communications in the bloodstream is a promising area of research, since the bloodstream has the ability to ...
Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...
A new blood test has an 80% accuracy in predicting preterm preeclampsia, according to a study published today, Feb. 12, in ...
A team of researchers has developed a "gut-on-chip" (a miniature model of the human intestine on a chip-sized device) capable ...
Researchers at the University of Toronto's Institute of Biomedical Engineering have found that studying blood flow in leg ...
RenovoRx, Inc. ("RenovoRx" or the "Company") (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and commercializing RenovoCath, an innovative, FDA-cleared device, ...
RenovoRx (RNXT) highlighted its recent abstract presentation at the 2025 Society of Interventional Oncology Annual Conference in Las Vegas, ...
Researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch applied to the skin. One day, researchers want to use switches of this kind to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback